Nisa Investment Advisors, LLC Kinnate Biopharma Inc. Transaction History

Nisa Investment Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$2.33 - $6.84 $65 - $191	-28 Reduced 6.31%	416 $1,000
Q1 2023 May 02, 2023	SELL	$3.46 - $7.98 $6,477 - $14,938	-1,872 Reduced 80.83%	444 $3,000
Q2 2022 Aug 03, 2022	BUY	$7.43 - $13.0 $3,090 - $5,408	416 Added 21.89%	2,316 $29,000
Q1 2022 Apr 29, 2022	BUY	$7.73 - $17.99 $14,687 - $34,181	1,900 New	1,900 $21,000

32.9M

94.7K

802K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.